日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer Patients

在癌症患者的 I 期研究中,评估食物和制剂对 SHP2 抑制剂 Migoprotafib 药代动力学的影响

Suchomel, Julia; Bowman, Christine M; Chiang, Po-Chang; Dhawan, Mallika; Eng-Wong, Jennifer; Hauser, Paloma; Johnson, Ryan; Muliadi, Ariel R; Pisupati, Swathi; Ramakrishnan, Vidya; Wagner, Leonie; Mandlekar, Sandhya V

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Divarasib联合西妥昔单抗治疗KRAS G12C阳性结直肠癌:一项1b期试验

Desai, Jayesh; Alonso, Guzman; Kim, Se Hyun; Cervantes, Andres; Karasic, Thomas; Medina, Laura; Shacham-Shmueli, Einat; Cosman, Rasha; Falcon, Alejandro; Gort, Eelke; Guren, Tormod; Massarelli, Erminia; Miller, Wilson H Jr; Paz-Ares, Luis; Prenen, Hans; Amatu, Alessio; Cremolini, Chiara; Kim, Tae Won; Moreno, Victor; Ou, Sai-Hong I; Passardi, Alessandro; Sacher, Adrian; Santoro, Armando; Stec, Rafal; Ulahannan, Susanna; Arbour, Kathryn; Lorusso, Patricia; Luo, Jia; Patel, Manish R; Choi, Yoonha; Shi, Zhen; Mandlekar, Sandhya; Lin, Mark T; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Han, Sae-Won

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy

获批用于癌症免疫治疗的检查点抑制剂的临床前表征进展及临床药理学见解

Sreeneeranj Kasichayanula #, Sandhya Mandlekar #, Vittal Shivva, Maulik Patel, Sandhya Girish

Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor

发现 5-苯基-N-(吡啶-2-基甲基)-2-(嘧啶-5-基)喹唑啉-4-胺是一种强效的 I Kur 抑制剂

Finlay, Heather J; Johnson, James A; Lloyd, John L; Jiang, Ji; Neels, James; Gunaga, Prashantha; Banerjee, Abhisek; Dhondi, Naveen; Chimalakonda, Anjaneya; Mandlekar, Sandhya; Conder, Mary Lee; Sale, Harinath; Xing, Dezhi; Levesque, Paul; Wexler, Ruth R

Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists

含烷基砜的三取代环己烷作为强效且生物利用度高的趋化因子受体2 (CCR2) 拮抗剂

Cherney, Robert J; Mo, Ruowei; Yang, Michael G; Xiao, Zili; Zhao, Qihong; Mandlekar, Sandhya; Cvijic, Mary Ellen; Charo, Israel F; Barrish, Joel C; Decicco, Carl P; Carter, Percy H

Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists

发现双取代环己烷作为一类新型 CC 趋化因子受体 2 拮抗剂

Robert J Cherney, Ruowei Mo, Dayton T Meyer, David J Nelson, Yvonne C Lo, Gengjie Yang, Peggy A Scherle, Sandhya Mandlekar, Zelda R Wasserman, Heather Jezak, Kimberly A Solomon, Andrew J Tebben, Percy H Carter, Carl P Decicco